209 related articles for article (PubMed ID: 3092711)
1. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.
Thadani U; Hamilton SF; Olson E; Anderson J; Voyles W; Prasad R; Teague SM
Ann Intern Med; 1986 Oct; 105(4):485-92. PubMed ID: 3092711
[TBL] [Abstract][Full Text] [Related]
2. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
[TBL] [Abstract][Full Text] [Related]
4. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.
Parker JO; Amies MH; Hawkinson RW; Heilman JM; Hougham AJ; Vollmer MC; Wilson RR
Circulation; 1995 Mar; 91(5):1368-74. PubMed ID: 7867175
[TBL] [Abstract][Full Text] [Related]
5. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval.
Schaer DH; Buff LA; Katz RJ
Am J Cardiol; 1988 Jan; 61(1):46-50. PubMed ID: 3122549
[TBL] [Abstract][Full Text] [Related]
6. [High-dose transdermal nitroglycerin therapy: loss of effect within 24 hours?].
Reiniger G; Kraus F; Dirschinger J; Blasini R; Rudolph W
Herz; 1985 Jun; 10(3):157-62. PubMed ID: 3926612
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the day-long antianginal effectiveness of nitroglycerin patches with that of three-times-daily isosorbide dinitrate: a double-blind study using dose titration.
Bassan MM; Rogel S
Eur Heart J; 1992 Sep; 13(9):1265-70. PubMed ID: 1396839
[TBL] [Abstract][Full Text] [Related]
8. [Interval therapy in effective treatment of angina pectoris using nitroglycerin patch systems. A controlled study with determination of nitroglycerin plasma levels].
Reiniger G; Menke G; Boertz A; Kraus F; Rudolph W
Herz; 1987 Feb; 12(1):68-73. PubMed ID: 3104180
[TBL] [Abstract][Full Text] [Related]
9. Transdermal nitroglycerin in angina pectoris.
Parker JO; Fung HL
Am J Cardiol; 1984 Sep; 54(6):471-6. PubMed ID: 6433687
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
[TBL] [Abstract][Full Text] [Related]
11. [Dose-response relationship of nitrate therapy of angina pectoris].
Schneider W; Kaltenbach M
Z Kardiol; 1986; 75 Suppl 3():61-7. PubMed ID: 3099486
[TBL] [Abstract][Full Text] [Related]
12. The day-long antianginal effectiveness of nitroglycerin patches. A double-blind study using dose-titration.
Bassan M
Chest; 1991 May; 99(5):1120-5. PubMed ID: 1902159
[TBL] [Abstract][Full Text] [Related]
13. Exercise capacity with transdermal nitroglycerin in patients with stable angina pectoris.
Naafs MA; de Boer AC; Koster RW; Klazen CW; Dunning AJ
Eur Heart J; 1984 Sep; 5(9):705-9. PubMed ID: 6437815
[TBL] [Abstract][Full Text] [Related]
14. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
Rezaković DE; Pavicić L; Majacić M
Eur Heart J; 1988 Jan; 9 Suppl A():73-81. PubMed ID: 3137073
[TBL] [Abstract][Full Text] [Related]
15. [Discontinuous drug release as an alternative to interval therapy in the treatment of coronary heart disease with nitroglycerin patches].
Reiniger G; Rudolph W
Herz; 1987 Oct; 12(5):348-53. PubMed ID: 3119443
[TBL] [Abstract][Full Text] [Related]
16. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin.
Nabel EG; Barry J; Rocco MB; Mead K; Selwyn AP
Am J Cardiol; 1989 Mar; 63(11):663-9. PubMed ID: 2493732
[TBL] [Abstract][Full Text] [Related]
17. Influence of transdermal nitrates on exercise capacity in patients with stable angina.
Thompson R
Angiology; 1986 Jun; 37(6):448-54. PubMed ID: 3089073
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.
James MA; Walker PR; Papouchado M; Wilkinson PR
Br Heart J; 1985 Jun; 53(6):631-5. PubMed ID: 3924081
[TBL] [Abstract][Full Text] [Related]
19. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.
Winsor T; Berger HJ
Am Heart J; 1975 Nov; 90(5):611-26. PubMed ID: 811102
[TBL] [Abstract][Full Text] [Related]
20. Effect of a new transdermal therapeutic system containing nitroglycerin on exercise capacity in patients with angina pectoris.
Scardi S; Pivotti F; Fonda F; Pandullo C; Castelli M; Pollavini G
Am Heart J; 1985 Sep; 110(3):546-51. PubMed ID: 3929579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
